GoodRx price target lowered to $4.25 from $4.50 at BofA
BofA lowered the firm’s price target on GoodRx (GDRX) to $4.25 from $4.50 and keeps an Underperform rating on the shares after the company ...
Becker's Hospital Review21h
Insulin prices at 10-year low: GoodRx
The average price per insulin unit hit a 10-year low in 2024, largely driven by federal actions and voluntary price cuts from drugmakers, according to a Jan. 15 GoodRx report. GoodRx analyzed the ...
ConsumerAffairs2d
GoodRx for Pets offers prescription discounts for pets
Pet owners now have a new online resource that can help them save money. GoodRx, a company known for offering consumers ...
GoodRx: A Business In Transition, But It Has Likely Reached Its Low (Rating Upgrade)
GoodRx returned to sequential growth in subscribers in Q3, showing potential for profit improvement. Read why I upgrade GDRX ...